{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anticoagulation", "Coagulation factor VIII", "Cobra venom", "Snake venom metalloproteinases", "Tissue-type fibrinogen activator"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38813202", "DateRevised": {"Year": "2024", "Month": "05", "Day": "31"}, "Article": {"Language": ["eng"], "ELocationID": ["e30969", "10.1016/j.heliyon.2024.e30969"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "12"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "10", "PubDate": {"Year": "2024", "Month": "May", "Day": "30"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system.", "Pagination": {"StartPage": "e30969", "MedlinePgn": "e30969"}, "Abstract": {"AbstractText": ["Snake venoms, comprising a complex array of protein-rich components, an important part of which are snake venom metalloproteinases (SVMPs). These SVMPs, which are predominantly isolated from viperid venoms, are integral to the pathology of snakebites. However, SVMPs derived from elapid venoms have not been extensively explored, and only a handful of SVMPs have been characterized to date. Atrase A, a nonhemorrhagic P-III class metalloproteinase from <i>Naja atra</i> venom, exhibits weak proteolytic activity against fibrinogen in vitro but has pronounced anticoagulant effects in vivo. This contrast spurred investigations into its anticoagulant mechanisms. Research findings indicate that atrase A notably extends the activated partial thromboplastin time, diminishes fibrinogen levels, and impedes platelet aggregation. The anticoagulant action of atrase A primarily involves inhibiting coagulation factor VIII and activating the endogenous fibrinolytic system, which in turn lowers fibrinogen levels. Additionally, its effect on platelet aggregation further contributes to its anticoagulant profile. This study unveils a novel anticoagulant mechanism of atrase A, significantly enriching the understanding of the roles of cobra venom metalloproteinases in snake venom. Furthermore, these findings underscore the potential of atrase A as a novel anticoagulant drug, offering insights into the functional evolutions of cobra venom metalloproteinases."], "CopyrightInformation": "\u00a9 2024 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang, 550014, China."}], "LastName": "Zhong", "ForeName": "Xin-Jie", "Initials": "XJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China."}], "LastName": "Wang", "ForeName": "Cai-E", "Initials": "CE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang, 550014, China."}], "LastName": "Li", "ForeName": "Ya-Nan", "Initials": "YN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang, 550014, China."}], "LastName": "Zhang", "ForeName": "Qi-Yun", "Initials": "QY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang, 550014, China."}], "LastName": "Sun", "ForeName": "Qian-Yun", "Initials": "QY"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Knudsen C., J\u00fcrgensen J.A., F\u00f8ns S., Haack A.M., Friis R.U.W., Dam S.H., Bush S.P., White J., Laustsen A.H. Snakebite envenoming diagnosis and Diagnostics. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.661457.", "ArticleIdList": ["10.3389/fimmu.2021.661457", "PMC8113877", "33995385"]}, {"Citation": "Guti\u00e9rrez J.M., Calvete J.J., Habib A.G., Harrison R.A., Williams D.J., Warrell D.A. Snakebite envenoming. Nat. Rev. Dis. Prim. 2017;3 doi: 10.1038/nrdp.2017.63.", "ArticleIdList": ["10.1038/nrdp.2017.63", "28980622"]}, {"Citation": "Casewell N.R., Jackson T.N.W., Laustsen A.H., Sunagar K. Causes and consequences of snake venom variation. Trends Pharmacol. Sci. 2020;41:570\u2013581. doi: 10.1016/j.tips.2020.05.006.", "ArticleIdList": ["10.1016/j.tips.2020.05.006", "PMC7116101", "32564899"]}, {"Citation": "Munawar A., Ali S., Akrem A., Betzel C. Snake venom peptides: tools of biodiscovery. Toxins. 2018;10:474. doi: 10.3390/toxins10110474.", "ArticleIdList": ["10.3390/toxins10110474", "PMC6266942", "30441876"]}, {"Citation": "Tasoulis T., Isbister G. A review and database of snake venom proteomes. Toxins. 2017;9:290. doi: 10.3390/toxins9090290.", "ArticleIdList": ["10.3390/toxins9090290", "PMC5618223", "28927001"]}, {"Citation": "Liu C.-C., Lin C.-C., Hsiao Y.-C., Wang P.-J., Yu J.-S. Proteomic characterization of six Taiwanese snake venoms: identification of species-specific proteins and development of a SISCAPA-MRM assay for cobra venom factors. J. Proteonomics. 2018;187:59\u201368. doi: 10.1016/j.jprot.2018.06.003.", "ArticleIdList": ["10.1016/j.jprot.2018.06.003", "29929037"]}, {"Citation": "Oliveira A.L., Viegas M.F., Da Silva S.L., Soares A.M., Ramos M.J., Fernandes P.A. The chemistry of snake venom and its medicinal potential. Nat. Rev. Chem. 2022;6:451\u2013469. doi: 10.1038/s41570-022-00393-7.", "ArticleIdList": ["10.1038/s41570-022-00393-7", "37117308"]}, {"Citation": "Takeda S., Takeya H., Iwanaga S. Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins. Biochim. Biophys. Acta Protein Proteonomics. 2012;1824:164\u2013176. doi: 10.1016/j.bbapap.2011.04.009.", "ArticleIdList": ["10.1016/j.bbapap.2011.04.009", "21530690"]}, {"Citation": "Sanchez E., Flores-Ortiz R., Alvarenga V., Eble J. Direct fibrinolytic snake venom metalloproteinases affecting hemostasis: structural, biochemical features and therapeutic potential. Toxins. 2017;9:392. doi: 10.3390/toxins9120392.", "ArticleIdList": ["10.3390/toxins9120392", "PMC5744112", "29206190"]}, {"Citation": "Guti\u00e9rrez J., Escalante T., Rucavado A., Herrera C. Hemorrhage caused by snake venom metalloproteinases: a journey of discovery and understanding. Toxins. 2016;8:93. doi: 10.3390/toxins8040093.", "ArticleIdList": ["10.3390/toxins8040093", "PMC4848620", "27023608"]}, {"Citation": "Fox J.W., Serrano S.M.T. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon. 2005;45:969\u2013985. doi: 10.1016/j.toxicon.2005.02.012.", "ArticleIdList": ["10.1016/j.toxicon.2005.02.012", "15922769"]}, {"Citation": "Fox J.W., Serrano S.M.T. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity: snake venom metalloproteinases and venom complexity. FEBS J. 2008;275:3016\u20133030. doi: 10.1111/j.1742-4658.2008.06466.x.", "ArticleIdList": ["10.1111/j.1742-4658.2008.06466.x", "18479462"]}, {"Citation": "Calvete J.J. Venomics: integrative venom proteomics and beyond. Biochem. J. 2017;474:611\u2013634. doi: 10.1042/BCJ20160577.", "ArticleIdList": ["10.1042/BCJ20160577", "28219972"]}, {"Citation": "Guti\u00e9rrez J., Escalante T., Rucavado A., Herrera C., Fox J. A comprehensive view of the structural and functional alterations of extracellular matrix by snake venom metalloproteinases (SVMPs): novel perspectives on the pathophysiology of envenoming. Toxins. 2016;8:304. doi: 10.3390/toxins8100304.", "ArticleIdList": ["10.3390/toxins8100304", "PMC5086664", "27782073"]}, {"Citation": "Ward C.M., Vinogradov D.V., Andrews R.K., Berndt M.C. Characterization of mocarhagin, a cobra venom metalloproteinase from Naja mocambique mocambique, and related proteins from other Elapidae venoms. Toxicon. 1996;34:1203\u20131206. doi: 10.1016/0041-0101(96)00115-8.", "ArticleIdList": ["10.1016/0041-0101(96)00115-8", "8931262"]}, {"Citation": "Olaoba O.T., Karina Dos Santos P., Selistre-de-Araujo H.S., Ferreira De Souza D.H. Snake venom metalloproteinases (SVMPs): a structure-function update. Toxicon. 2020;X 7 doi: 10.1016/j.toxcx.2020.100052.", "ArticleIdList": ["10.1016/j.toxcx.2020.100052", "PMC7399193", "32776002"]}, {"Citation": "Asega A.F., Menezes M.C., Trevisan-Silva D., Cajado-Carvalho D., Bertholim L., Oliveira A.K., Zelanis A., Serrano S.M.T. Cleavage of proteoglycans, plasma proteins and the platelet-derived growth factor receptor in the hemorrhagic process induced by snake venom metalloproteinases. Sci. Rep. 2020;10 doi: 10.1038/s41598-020-69396-y.", "ArticleIdList": ["10.1038/s41598-020-69396-y", "PMC7395112", "32737331"]}, {"Citation": "Wei J., Mo Y., Qiao L., Wei X., Chen H., Xie H., Fu Y., Wang W., Xiong Y., He S. Potent histamine-releasing activity of atrahagin, a novel snake venom metalloproteinase. Int. J. Biochem. Cell Biol. 2006;38:510\u2013520. doi: 10.1016/j.biocel.2005.10.011.", "ArticleIdList": ["10.1016/j.biocel.2005.10.011", "16310401"]}, {"Citation": "Baldo C., Jamora C., Yamanouye N., Zorn T.M., Moura-da-Silva A.M. Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. PLoS Neglected Trop. Dis. 2010;4:e727. doi: 10.1371/journal.pntd.0000727.", "ArticleIdList": ["10.1371/journal.pntd.0000727", "PMC2894137", "20614020"]}, {"Citation": "Escalante T., Rucavado A., Fox J.W., Guti\u00e9rrez J.M. Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases. J. Proteonomics. 2011;74:1781\u20131794. doi: 10.1016/j.jprot.2011.03.026.", "ArticleIdList": ["10.1016/j.jprot.2011.03.026", "21447411"]}, {"Citation": "Herrera C., Escalante T., Voisin M.-B., Rucavado A., Moraz\u00e1n D., Mac\u00eado J.K.A., Calvete J.J., Sanz L., Nourshargh S., Guti\u00e9rrez J.M., Fox J.W. Tissue localization and extracellular matrix degradation by PI, PII and PIII snake venom metalloproteinases: clues on the mechanisms of venom-induced hemorrhage. PLoS Neglected Trop. Dis. 2015;9 doi: 10.1371/journal.pntd.0003731.", "ArticleIdList": ["10.1371/journal.pntd.0003731", "PMC4409213", "25909592"]}, {"Citation": "Kini R., Koh C. Metalloproteases affecting blood coagulation, fibrinolysis and platelet aggregation from snake venoms: definition and nomenclature of interaction sites. Toxins. 2016;8:284. doi: 10.3390/toxins8100284.", "ArticleIdList": ["10.3390/toxins8100284", "PMC5086644", "27690102"]}, {"Citation": "Moura-da-Silva A.M., Ramos O.H.P., Baldo C., Niland S., Hansen U., Ventura J.S., Furlan S., Butera D., Della-Casa M.S., Tanjoni I., Clissa P.B., Fernandes I., Chudzinski-Tavassi A.M., Eble J.A. Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases. Biochimie. 2008;90:484\u2013492. doi: 10.1016/j.biochi.2007.11.009.", "ArticleIdList": ["10.1016/j.biochi.2007.11.009", "18096518"]}, {"Citation": "Sun Q.Y., Li M., Yang M.F. Purification and characterization of a metalloproteinase with weak fibrinogenolytic activity from Naja atra venom. Chinese Journal of Biochemistry and Molecular Biology. 2007;23:835\u2013843. doi: 10.3969/j.issn.1007-7626.2007.10.008.", "ArticleIdList": ["10.3969/j.issn.1007-7626.2007.10.008"]}, {"Citation": "Sun Q.Y., Bao J. Purification, cloning and characterization of a metalloproteinase from Naja atra venom. Toxicon. 2010;56:1459\u20131469. doi: 10.1016/j.toxicon.2010.08.013.", "ArticleIdList": ["10.1016/j.toxicon.2010.08.013", "20837040"]}, {"Citation": "Butenas S., Mann K.G. Blood coagulation. Biochemistry. Biokhimiia. 2002;67:3\u201312. doi: 10.1023/a:1013985911759.", "ArticleIdList": ["10.1023/a:1013985911759", "11841335"]}, {"Citation": "Wang C.E., Sun Q.Y., Li M., Shi J.S. Antiplatelet aggregation effect and mechanism of cobra venom metalloproteinase atrase A. Chinese Journal of Pharmacological Bulletin. 2009;25:743\u2013747."}, {"Citation": "Camire R.M. Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics. J. Thromb. Thrombolysis. 2021;52:383\u2013390. doi: 10.1007/s11239-021-02456-w.", "ArticleIdList": ["10.1007/s11239-021-02456-w", "PMC8531165", "33886037"]}, {"Citation": "Fay P.J. Activation of factor VIII and mechanisms of cofactor action. Blood Rev. 2004;18:1\u201315. doi: 10.1016/S0268-960X(03)00025-0.", "ArticleIdList": ["10.1016/S0268-960X(03)00025-0", "14684146"]}, {"Citation": "Weitz J.I., Fredenburgh J.C., Eikelboom J.W. A test in context: D-dimer. J. Am. Coll. Cardiol. 2017;70:2411\u20132420. doi: 10.1016/j.jacc.2017.09.024.", "ArticleIdList": ["10.1016/j.jacc.2017.09.024", "29096812"]}, {"Citation": "Winter W.E., Greene D.N., Beal S.G., Isom J.A., Manning H., Wilkerson G., Harris N. Advances in Clinical Chemistry. Elsevier; 2020. Clotting factors: clinical biochemistry and their roles as plasma enzymes; pp. 31\u201384.", "ArticleIdList": ["10.1016/bs.acc.2019.07.008", "31952574"]}, {"Citation": "P. Gaffney, Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications, J. Clin. Pathol. Suppl., 14, 10\u201317.", "ArticleIdList": ["PMC1347099", "6448869"]}, {"Citation": "Zhang Y., Wisner A., Xiong Y., Bon C. A novel plasminogen activator from snake venom. J. Biol. Chem. 1995;270:10246\u201310255. doi: 10.1074/jbc.270.17.10246.", "ArticleIdList": ["10.1074/jbc.270.17.10246", "7730329"]}, {"Citation": "Lan D., Song S., Liu Y., Jiao B., Meng R. Use of batroxobin in central and peripheral ischemic vascular diseases: a systematic review. Front. Neurol. 2021;12 doi: 10.3389/fneur.2021.716778.", "ArticleIdList": ["10.3389/fneur.2021.716778", "PMC8675357", "34925203"]}, {"Citation": "Oyama E., Takahashi H. Structures and functions of snake venom metalloproteinases (SVMP) from Protobothrops venom collected in Japan. Molecules. 2017;22:1305. doi: 10.3390/molecules22081305.", "ArticleIdList": ["10.3390/molecules22081305", "PMC6152190", "28777331"]}, {"Citation": "Baldo C., Tanjoni I., Le\u00f3n I.R., Batista I.F.C., Della-Casa M.S., Clissa P.B., Weinlich R., Lopes-Ferreira M., Lebrun I., Amarante-Mendes G.P., Rodrigues V.M., Perales J., Valente R.H., Moura-da-Silva A.M. BnP1, a novel P-I metalloproteinase from Bothrops neuwiedi venom: biological effects benchmarking relatively to jararhagin, a P-III SVMP. Toxicon. 2008;51:54\u201365. doi: 10.1016/j.toxicon.2007.08.005.", "ArticleIdList": ["10.1016/j.toxicon.2007.08.005", "17889921"]}, {"Citation": "Moura-da-Silva A.M., Baldo C. Jararhagin, a hemorrhagic snake venom metalloproteinase from Bothrops jararaca. Toxicon. 2012;60:280\u2013289. doi: 10.1016/j.toxicon.2012.03.026.", "ArticleIdList": ["10.1016/j.toxicon.2012.03.026", "22534074"]}, {"Citation": "Sugiki M., Maruyama M., Yoshida E., Mihara H., Kamiguti A.S., Theakston R.DavidG. Enhancement of plasma fibrinolysis in vitro by jararhagin, the main haemorrhagic metalloproteinase in Bothrops jararaca venom. Toxicon. 1995;33:1605\u20131617. doi: 10.1016/0041-0101(95)00102-6.", "ArticleIdList": ["10.1016/0041-0101(95)00102-6", "8866618"]}, {"Citation": "Oliveira A.K., Paes Leme A.F., Assakura M.T., Menezes M.C., Zelanis A., Tashima A.K., Lopes-Ferreira M., Lima C., Camargo A.C.M., Fox J.W., Serrano S.M.T. Simplified procedures for the isolation of HF3, bothropasin, disintegrin-like/cysteine-rich protein and a novel P-I metalloproteinase from Bothrops jararaca venom. Toxicon. 2009;53:797\u2013801. doi: 10.1016/j.toxicon.2009.02.019.", "ArticleIdList": ["10.1016/j.toxicon.2009.02.019", "19254739"]}, {"Citation": "Silva M.B., Schattner M., Ramos C.R.R., Junqueira-de-Azevedo I.L.M., Guarnieri M.C., Lazzari M.A., Sampaio C.A.M., Pozner R.G., Ventura J.S., Ho P.L., Chudzinski-Tavassi A.M. A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning. Biochem. J. 2003;369:129\u2013139. doi: 10.1042/bj20020449.", "ArticleIdList": ["10.1042/bj20020449", "PMC1223056", "12225292"]}, {"Citation": "Rietveld I.M., Lijfering W.M., Le Cessie S., Bos M.H.A., Rosendaal F.R., Reitsma P.H., Cannegieter S.C. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. J. Thromb. Haemostasis. 2019;17:99\u2013109. doi: 10.1111/jth.14343.", "ArticleIdList": ["10.1111/jth.14343", "30471183"]}, {"Citation": "Bombeli T., Jutzi M., De Conno E., Seifert B., Fehr J. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins. Blood Coagul. Fibrinolysis. 2002;13:577\u2013581. doi: 10.1097/00001721-200210000-00001.", "ArticleIdList": ["10.1097/00001721-200210000-00001", "12439142"]}, {"Citation": "Agnelli G. Rationale for bolus t-PA therapy to improve efficacy and safety. Chest. 1990;97:161S\u2013167S. doi: 10.1378/chest.97.4_Supplement.161S.", "ArticleIdList": ["10.1378/chest.97.4_Supplement.161S", "2108853"]}]}], "History": [{"Year": "2024", "Month": "1", "Day": "30"}, {"Year": "2024", "Month": "5", "Day": "7"}, {"Year": "2024", "Month": "5", "Day": "8"}, {"Year": "2024", "Month": "5", "Day": "30", "Hour": "6", "Minute": "36"}, {"Year": "2024", "Month": "5", "Day": "30", "Hour": "6", "Minute": "35"}, {"Year": "2024", "Month": "5", "Day": "30", "Hour": "4", "Minute": "0"}, {"Year": "2024", "Month": "5", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["38813202", "PMC11133756", "10.1016/j.heliyon.2024.e30969", "S2405-8440(24)07000-2"]}}]}